Capital Management Associates (New York) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MP Materials
MP
|
+$1.1M |
| 2 |
Freeport-McMoran
FCX
|
+$1.09M |
| 3 |
Celestica
CLS
|
+$1.05M |
| 4 |
CVS Health
CVS
|
+$803K |
| 5 |
Micron Technology
MU
|
+$637K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bloom Energy
BE
|
+$1.02M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.8% |
| 2 | Industrials | 18.56% |
| 3 | Healthcare | 8.56% |
| 4 | Miscellaneous | 8.25% |
| 5 | Financials | 7.9% |
Similar funds
Capital Management Associates (New York)'s Q2 2026 Portfolio in Review
As of Q2 2026, Capital Management Associates (New York) held 44 positions worth $77.7M, up 29% from $60.2M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Capital Management Associates (New York) deployed $5.29M of net new capital in Q2 2026, opening 8 new positions. Its largest new stake was MP Materials: 18,000 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Bloom Energy, an estimated $1.02M trimmed.
- Capital Management Associates (New York)'s largest Q2 2026 buy was MP Materials: 18,000 shares worth $1.01M.
- Capital Management Associates (New York)'s biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $1.02M.
- Capital Management Associates (New York)'s ten largest holdings make up 46% of its $77.7M portfolio in Q2 2026.
- Capital Management Associates (New York) opened 8 new positions and closed 0 in Q2 2026.
- Capital Management Associates (New York)'s portfolio value rose 29% quarter-over-quarter to $77.7M.
Based on Capital Management Associates (New York)'s 13F filing for Q2 2026, filed 10 Aug 2026.